Market Tracker

08/18 5:16pm ET

Aviragen Therapeutics Inc (NASDAQ:AVIR)

During the Trading Day
0.5963 +0.0263 / +4.61%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
0.595 -0.0013 / -0.22%
 
Volume: 4.1K
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close0.57
Today’s open0.58
Day’s range0.58 - 0.60
Volume39,638
Average volume (3 months)351,333
Market cap$22.0M
Dividend yield--
Data as of 3:59pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-22.22%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-62.20%
P/E ratioNM
Price/Sales5.82
Price/Book0.48

Competitors

 Today’s
change
Today’s
% change
PRANPrana Biotechnology ...+0.07+2.81%
AXNAoxing Pharmaceutica...+0.02+5.38%
XBIOXenetic Biosciences ...0.000.00%
TNXPTonix Pharmaceutical...-0.02-0.67%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateSeptember 14, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$9.3M
Annual profit (last year)-$25.4M
Net profit margin-273.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Executive Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts